Fetal‐haemoglobin enhancing genotype at BCL11A reduces HbA(2) levels in patients with sickle cell anaemia

Understanding the interplay of genetic factors with haemoglobin expression and pathological processes in sickle cell disease is important for pharmacological and gene‐therapeutic interventions. In our nascent study cohort of Nigerian patients, we found that three major disease‐modifying factors, HbF...

Descripción completa

Detalles Bibliográficos
Autores principales: Adeyemo, Titilope A., Ojewunmi, Oyesola O., Oyetunji, Idayat Ajoke, Kalejaiye, Olufunto Olufela, Menzel, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175773/
https://www.ncbi.nlm.nih.gov/pubmed/35844678
http://dx.doi.org/10.1002/jha2.186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175773/
https://www.ncbi.nlm.nih.gov/pubmed/35844678
http://dx.doi.org/10.1002/jha2.186

Ejemplares similares